Kolmak Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 2.00 Cr
as on 21-06-2024
- Company Age 47 Year, 3 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 3.00 Cr
as on 21-06-2024
- Satisfied Charges ₹ 9.33 Cr
as on 21-06-2024
- Revenue %
(FY 2017)
- Profit 97.33%
(FY 2017)
- Ebitda 97.33%
(FY 2017)
- Net Worth -0.02%
(FY 2017)
- Total Assets 0.07%
(FY 2017)
About Kolmak Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹9.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravivarmanthampi Krishnaprasad, Balagangadharan Suyambulingamuthu, and Prabu Christopher serve as directors at the Company.
- CIN/LLPIN
U17297WB1977PLC031162
- Company No.
031162
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Sep 1977
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Nadia, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Kolmak Chemicals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ravivarmanthampi Krishnaprasad | Director | 19-Oct-2011 | Current |
Balagangadharan Suyambulingamuthu | Director | 05-Nov-2013 | Current |
Prabu Christopher | Director | 20-Nov-2013 | Current |
Financial Performance of Kolmak Chemicals.
Kolmak Chemicals Ltd., for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.33% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kolmak Chemicals?
In 2017, Kolmak Chemicals had a promoter holding of 65.98% and a public holding of 34.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bharat Maintenance Contracting Leasing Private Limited Creation Date: 20 Mar 2014 | ₹3.00 Cr | Open |
Idbi Bank Limited Creation Date: 30 Sep 2010 | ₹4.00 Cr | Satisfied |
State Bank Of India Creation Date: 23 Mar 2005 | ₹3.20 Cr | Satisfied |
How Many Employees Work at Kolmak Chemicals?
Unlock and access historical data on people associated with Kolmak Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kolmak Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kolmak Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.